UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Vascular endothelial growth factor inhibits the development of dendritic cells and dramatically affects the differentiation of multiple hematopoietic lineages in vivo

Blood, 1998-12, Vol.92 (11), p.4150-4166

1998

Volltextzugriff (PDF)

Overview

Rinshō ketsueki, 2017, Vol.58 (5), p.458

Ishida, Tadao

2017

Volltextzugriff (PDF)

Multiple Myeloma: from Diagnosis to the Up-to-date Treatment. Topics: II. The Diagnosis of Multiple Myeloma

Nihon Naika Gakkai zasshi, 2016-07, Vol.105 (7), p.1209-1215

Ishida, Tadao

2016

Volltextzugriff (PDF)

Complications and managements in treatment of melphalan, prednisone and new agents

Nihon rinshō, 2015-02, Vol.73 Suppl 2, p.649

Ishida, Tadao

2015

Volltextzugriff (PDF)

Cytogenetic abnormalities in high-risk multiple myeloma

Nihon rinshō, 2015-01, Vol.73 (1), p.28

Ishida, Tadao

2015

Volltextzugriff (PDF)

Chromosomal abnormalities and clonal evolution in multiple myeloma

Rinshō ketsueki, 2014-10, Vol.55 (10), p.2036

Ishida, Tadao

2014

Volltextzugriff (PDF)

II. Immunomodulation for multiple myeloma

Gan to kagaku ryoho, 2013-05, Vol.40 (5), p.589

Ishida, Tadao

2013

Volltextzugriff (PDF)

Triplets therapy for the patients of multiple myeloma

Nihon rinshō, 2013-09, Vol.71 (9), p.1691

Ishida, Tadao

2013

Volltextzugriff (PDF)

Multiple myeloma: chromosomal abnormalities, clinical features and prognosis

Rinshō ketsueki, 2013-10, Vol.54 (10), p.1856

Ishida, Tadao

2013

Volltextzugriff (PDF)

Myeloma therapy(2) Treatment of transplant-ineligible patients

Rinshō ketsueki, 2013-08, Vol.54 (8), p.711

Ishida, Tadao

2013

Volltextzugriff (PDF)

Usefulness of serum free light-chain assay for evaluation of therapeutic efficacy in non-secretory multiple myeloma

Rinshō ketsueki, 2013-01, Vol.54 (1), p.122

2013

Volltextzugriff (PDF)

Retrospective analysis of allogeneic hematopoietic stem cell transplantation for multiple myeloma after myeloablative conditioning with 8 Gy of total body irradiation

Rinshō ketsueki, 2024, Vol.65 (7), p.615

2024

Volltextzugriff (PDF)

A retrospective analysis of 124 patients with multiple myeloma who received up-front autologous hematopoietic cell transplantation following triplet induction therapy

Rinshō ketsueki, 2023, Vol.64 (11), p.1397

2023

Volltextzugriff (PDF)

Meta-analysis of Multiple Myeloma and Benzene Exposure

Journal of Epidemiology, 2001, Vol.11(6), pp.249-254

2001

Volltextzugriff (PDF)

Successful treatment with thalidomide-combined therapy in an amyloidosis-complicated multiple myeloma patient refractory to bortezomib, lenalidomide, and pomalidomide

Rinshō ketsueki, 2018, Vol.59 (3), p.275

2018

Volltextzugriff (PDF)

The analysis of interleukin-6 in patients with systemic IgG4-related plasmacytic syndrome—expansion of SIPS to the territory of Castleman's disease

Rheumatology (Oxford, England), 2009-07, Vol.48 (7), p.860-862

2009

Volltextzugriff (PDF)

Cost-effectiveness of peripheral blood stem cell collection using plerixafor: a single-center study

Rinshō ketsueki, 2020, Vol.61 (11), p.1563

2020

Volltextzugriff (PDF)

Chemotherapy for multiple myeloma

Nihon rinshō, 2007-12, Vol.65 (12), p.2280

Ishida, Tadao

2007

Volltextzugriff (PDF)

Elotuzumab treatment for a multiple myeloma patient relapsing after allogenic stem cell transplantation

Rinshō ketsueki, 2019, Vol.60 (12), p.1635

2019

Volltextzugriff (PDF)

Efficacy of plerixafor in autologous peripheral blood stem cell collection

Rinshō ketsueki, 2019, Vol.60 (3), p.165

2019

Volltextzugriff (PDF)

Safety and management of adverse events of ixazomib/lenalidomide/dexamethasone therapy in Japanese patients with relapsed/refractory multiple myeloma

Rinshō ketsueki, 2018, Vol.59 (11), p.2399

2018

Volltextzugriff (PDF)

Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis during pregnancy

Rinshō ketsueki, 2017, Vol.58 (3), p.216

2017

Volltextzugriff (PDF)

IgE-κ type multiple myeloma achieving complete response with novel agents

Rinshō ketsueki, 2017, Vol.58 (11), p.2232

2017

Volltextzugriff (PDF)

A case of primary mediastinal (Thymic) B-cell lymphoma successfully treated with the DA-EPOCH-R Regimen

Gan to kagaku ryoho, 2015-01, Vol.42 (1), p.119

2015

Volltextzugriff (PDF)

Sustained complete molecular remission after cessation of imatinib mesylate treatment in a patient with relapsed chronic myelogenous leukemia after allogeneic stem cell transplantation

Rinshō ketsueki, 2012-02, Vol.53 (2), p.215

2012

Volltextzugriff (PDF)

1 – 25 von 53

Suche als RSS-Feed

Aktive Filter

ThemaScience & Technology

KollektionMEDLINE

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(16)
Mit Volltextzugriff
(16)

Publikationsform

Artikel
(53)

Sprache

Japanisch
(37)
Englisch
(16)

Erscheinungsjahr

n.n

Thema

Humans
(49)
Male
(17)
Female
(16)
Adult
(13)
Middle Aged
(12)
Aged
(9)
Multiple Myeloma
(9)
Multiple Myeloma - Drug Therapy
(9)
Animals
(8)
Treatment Outcome
(8)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(7)
Bortezomib
(7)
Multiple Myeloma - Therapy
(7)
Risk Factors
(5)
Boronic Acids - Administration & Dosage
(4)
Drug Therapy, Combination
(4)
Hematopoietic Stem Cell Transplantation
(4)
Mice
(4)
Pyrazines - Administration & Dosage
(4)
Remission Induction
(4)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Vascular endothelial growth factor inhibits the development of dendritic cells and dramatically affects the differentiation of multiple hematopoietic lineages in vivo

Overview

Multiple Myeloma: from Diagnosis to the Up-to-date Treatment. Topics: II. The Diagnosis of Multiple Myeloma

Complications and managements in treatment of melphalan, prednisone and new agents

Cytogenetic abnormalities in high-risk multiple myeloma

Chromosomal abnormalities and clonal evolution in multiple myeloma

II. Immunomodulation for multiple myeloma

Triplets therapy for the patients of multiple myeloma

Multiple myeloma: chromosomal abnormalities, clinical features and prognosis

Myeloma therapy(2) Treatment of transplant-ineligible patients

Usefulness of serum free light-chain assay for evaluation of therapeutic efficacy in non-secretory multiple myeloma

Retrospective analysis of allogeneic hematopoietic stem cell transplantation for multiple myeloma after myeloablative conditioning with 8 Gy of total body irradiation

A retrospective analysis of 124 patients with multiple myeloma who received up-front autologous hematopoietic cell transplantation following triplet induction therapy

Meta-analysis of Multiple Myeloma and Benzene Exposure

Successful treatment with thalidomide-combined therapy in an amyloidosis-complicated multiple myeloma patient refractory to bortezomib, lenalidomide, and pomalidomide

The analysis of interleukin-6 in patients with systemic IgG4-related plasmacytic syndrome—expansion of SIPS to the territory of Castleman's disease

Cost-effectiveness of peripheral blood stem cell collection using plerixafor: a single-center study

Chemotherapy for multiple myeloma

Elotuzumab treatment for a multiple myeloma patient relapsing after allogenic stem cell transplantation

Efficacy of plerixafor in autologous peripheral blood stem cell collection

Safety and management of adverse events of ixazomib/lenalidomide/dexamethasone therapy in Japanese patients with relapsed/refractory multiple myeloma

Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis during pregnancy

IgE-κ type multiple myeloma achieving complete response with novel agents

A case of primary mediastinal (Thymic) B-cell lymphoma successfully treated with the DA-EPOCH-R Regimen

Sustained complete molecular remission after cessation of imatinib mesylate treatment in a patient with relapsed chronic myelogenous leukemia after allogeneic stem cell transplantation

Aktive Filter

Suchergebnisse filtern